(Press-News.org) A four-year, $3.4 million grant to investigate molecular mechanisms and therapeutic treatments for acute respiratory distress syndrome (ARDS) has been awarded to UTHealth Houston researchers by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health.
The study led by principal investigators Holger Eltzschig, MD, PhD, professor and chair of the Department of Anesthesiology, Critical Care and Pain Medicine at McGovern Medical School at UTHealth Houston, and Xiaoyi Yuan, PhD, assistant professor in the department, is built on many years of research in the endogenous protective pathways in ARDS.
“We are further understanding how the human body responds to different insults in the lung to identify molecular mechanisms that could be targeted pharmacologically,” Yuan said. “Our ultimate goal is to translate our research from bench to bedside to improve clinical outcomes of ARDS.”
ARDS is a severe lung condition that develops from direct insult in the lung, such as ventilation-induced lung injury or COVID-19 infection, and systemic inflammation, such as sepsis. Fluid builds up in tiny elastic air sacs called alveoli and during severe conditions, it deprives the lungs and major organs of oxygen. This causes the body to go into hypoxia, a life-threatening state of low oxygen. Currently, there are limited pharmacological strategies for ARDS.
Hypoxia-inducible factors (HIFs) are stabilized in alveoli cells to provide lung protection during ARDS. Prolyl hydroxylases (PHDs) are enzymes that control the protein levels of HIFs when oxygen is abundant. In a hypoxic state, less active PHDs allow HIFs to accumulate, promoting angiogenesis, alleviating inflammation, and supporting oxygen delivery to lung tissue.
“It is important to design preclinical studies to facilitate clinical translation,” Yuan said.
Many previous studies in murine models of ARDS employ therapeutic strategies before the onset of ARDS. Their conclusion is unfortunately rarely translated into the clinic. With concepts adopted from ongoing clinical studies, the investigators will use HIF-PHD inhibitor compounds and other therapeutic strategies to target molecular pathways after the onset of ARDS in preclinical murine models.
“Our model systems are highly translational and relevant to human ARDS caused by ventilator usage, sepsis, and SARS-CoV-2. We are very optimistic that using HIF-PHD inhibitor compounds will evolve as a new approach to either prevent or treat lung inflammation among a wide range of patients,” said Eltzschig, the John P. and Kathrine G. McGovern Distinguished University Chair and the director of the Center for Perioperative Medicine at the medical school.
COVID-19-associated cases of ARDS have become rare because the recent various strains of COVID-19 are not causing severe outcomes. The team’s next step is to conduct separate independent studies analyzing the use of pharmaceutical HIF-PHD inhibitors to treat ARDS that occur from infection caused by other viral and bacterial diseases.
UTHealth Houston co-investigators on the study are Marie-Françoise Doursout, PhD, professor in the Department of Anesthesiology, Critical Care and Pain Medicine; Charles Green, PhD, professor in the Department of Pediatrics; and Harry Karmouty-Quintana, PhD, associate professor in the Department of Biochemistry and Molecular Biology and Fellow of the William S. Kilroy Sr. Distinguished University Chair in Pulmonary Disease, with McGovern Medical School. This research is funded by NIH grant R01HL169519.
Media Inquiries: 713-500-3030
END
UTHealth Houston researchers awarded $3.4M NIH grant to study pharmaceutical therapies to treat acute respiratory distress syndrome
2023-10-26
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Renewed support for high power laser facilities will benefit discovery science and inertial fusion energy research at SLAC
2023-10-26
Research and technology development for plasma physics and fusion energy at the Department of Energy’s SLAC National Accelerator Laboratory just got a boost from a LaserNetUS award.
In total, the DOE’s Office of Science awarded $28.5 million to advance discovery science and inertial fusion energy, including a three-year grant for the development and operations of the Matter in Extreme Conditions (MEC) instrument at SLAC’s Linac Coherent Light Source (LCLS).
MEC has been home to high intensity laser experiments since 2012, and joined ...
TUM professor develops energy-saving AI chip
2023-10-26
The basic idea is simple: unlike previous chips, where only calculations were carried out on transistors, they are now the location of data storage as well. That saves time and energy. “As a result, the performance of the chips is also boosted,” says Hussam Amrouch, a professor of AI processor design at the Technical University of Munich (TUM). The transistors on which he performs calculations and stores data measure just 28 nanometers, with millions of them placed on each of the new AI chips. The chips of the future will have to be faster and more efficient than earlier ones. Consequently, ...
SETI Institute artist-in-residence Daniela De Paulis to receive 2023 Europlanet Prize for Public Engagement
2023-10-26
SETI Institute Artist-in-Residence Daniela De Paulis to Receive 2023 Europlanet Prize for Public Engagement
Daniela de Paulis is honored for her work bringing space and planetary science to international audiences.
October 26, 2023, Mountain View, CA -- The SETI Institute is thrilled to announce that Daniela De Paulis, a SETI Artist-in-Residence (SETI AIR), will be honored with the prestigious 2023 Europlanet Prize for Public Engagement. De Paulis’ groundbreaking project, ‘A Sign in Space,’ invited a global audience to participate in decoding a simulated message from an extraterrestrial ...
Genomic screening to identify iron overload encourages patients to seek treatment and condition management, study finds
2023-10-26
DANVILLE, Pa. – Genomic screening to identify hemochromatosis—a disorder that causes iron levels in the body to rise to dangerous levels—encourages people with the condition to seek treatment and ongoing management, a Geisinger study found.
Hereditary hemochromatosis type 1 (HH1), caused by a change in the HFE gene, is underdiagnosed, often resulting in missed opportunities for early and consistent treatment. Without treatment, hemochromatosis can cause iron overload, a buildup of iron that can damage many parts of the body. Treatment of hemochromatosis includes regular monitoring of iron levels and removing excess iron ...
People with autism less likely to succumb to bystander effect, York University father-son research duo finds
2023-10-26
People with autism less likely to succumb to bystander effect, York U father-son research duo finds
Schulich School of Business and Faculty of Health researchers say that while as many as 90 per cent of people with autism are unemployed or underemployed, their study points to the benefits of having neurodivergent people in the workplace
TORONTO, Oct. 26, 2023 — A well-established psychological theory states that most of us are less likely to intervene in a bad situation if other people are present, and this ‘bystander effect’ also applies to workplace settings. However, new research led ...
UTSA receives $500,000 US Economic Development Administration grant to build secure manufacturing hub in South Texas
2023-10-26
(San Antonio, October 26, 2023) -- The Cybersecurity Manufacturing Innovation Institute (CyManII) at The University of Texas at San Antonio (UTSA) has been selected by the U.S. Economic Development Administration (EDA) to establish an ecosystem that will promote secure manufacturing strategies across South Texas. The Secure Manufacturing in South Texas Strategy Development Consortium, funded by a $500,000 Tech Hubs Strategy Development Grant, will enable CyManII to take initial steps to develop a Secure Manufacturing Tech Hub that will mature technologies, enhance business competitiveness ...
Asian American Engineer of the Year goes to Sandia Labs computer scientist
2023-10-26
ALBUQUERQUE, N.M. — Tian Ma, a distinguished computer engineer in research and development at Sandia National Laboratories, has been honored as a 2023 Asian American Engineer of the Year by the Chinese Institute of Engineers-USA. Each year, CIE recognizes exceptional Asian American engineers who demonstrate strong technical skills, leadership abilities and a commitment to public service. Previous recipients of this award include Nobel laureates and astronauts.
Ma’s expertise in data analysis and processing has propelled him to national recognition as an expert in detection algorithms and tracking systems. His journey ...
Venus had Earth-like plate tectonics billions of years ago, study suggests
2023-10-26
PROVIDENCE, R.I. [Brown University] — Venus, a scorching wasteland of a planet according to scientists, may have once had tectonic plate movements similar to those believed to have occurred on early Earth, a new study found. The finding sets up tantalizing scenarios regarding the possibility of early life on Venus, its evolutionary past and the history of the solar system.
Writing in Nature Astronomy, a team of scientists led by Brown University researchers describes using atmospheric data from Venus and computer modeling to show that the composition of the planet’s current atmosphere and surface pressure would only have been possible as a result of an early form of plate ...
Machine learning study looks at younger population to identify, mitigate cardiometabolic risks
2023-10-26
BINGHAMTON, N.Y. -- A researcher at Binghamton University, State University of New York will lead a $2.5 million project from the National Institutes of Health to develop machine models to identify and predict cardiometabolic risks in adolescents and young adults.
Cardiometabolic diseases are the top cause of preventable deaths worldwide, and the number of people who experience one or more of these conditions during their lifetime is increasing.
Still, much of the research about these diseases has focused on the adult and senior populations. What if younger people and the healthcare professionals who ...
Study seeks new treatments for post-traumatic stress disorder in veterans, military personnel
2023-10-26
A groundbreaking clinical trial launched October 16 will explore the promise of new drug treatments for military personnel and veterans suffering from post-traumatic stress disorder (PTSD). The multi-site trial is spearheaded by the U.S. Army Medical Materiel Development Activity (USAMMDA), part of the U.S. Army Medical Research and Development Command, and supported by a project team that includes representatives from the U.S. Air Force, Army, Navy, and Special Operations Command.
Military veterans are more likely to have PTSD than civilians, according to statistics from the U.S. Department of Veterans Affairs, and service members who deployed to ...